Subscribe to RSS
DOI: 10.1055/a-2697-3029
The Role of Oral Isotretinoin in Thick Skin Rhinoplasty: A Systematic Review
Authors
Abstract
Introduction
Thick skin poses a challenge in rhinoplasty, often resulting in an undefined tip and supratip deformities.
Objectives and Hypotheses
This study evaluates oral isotretinoin as an adjuvant treatment for thick-skinned rhinoplasty patients.
Study Design
This is a systematic review conducted in accordance with PRISMA guidelines.
Methods
Two independent investigators performed a comprehensive literature search to identify studies that assessed perioperative oral isotretinoin treatment in thick skin rhinoplasty patients. Key outcome measures include skin thickness reduction, cosmetic surgical outcomes, and postoperative patient satisfaction.
Results
Five studies met the study inclusion criteria. Their findings demonstrated that oral isotretinoin effectively reduces skin thickness and improves cosmetic outcomes and satisfaction up to 6 months postoperatively, with no major complications reported.
Conclusion
Although evidence is limited, oral isotretinoin shows promise in enhancing short-term rhinoplasty outcomes for thick-skinned patients. Further, high-quality trials are needed to confirm these results and develop standardized treatment protocols.
Contributors' Statement
All the authors contributed to the data collection, synthesis of results, and completion of the review. H.M.Y. wrote the first draft of the article. I.F-C. and S.P. were involved in study design, editing, and supervision of this research project. All authors reviewed the article prior to publication.
Publication History
Received: 25 July 2025
Accepted: 06 September 2025
Accepted Manuscript online:
08 September 2025
Article published online:
17 September 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Triana L, Palacios Huatuco RM, Campilgio G, Liscano E. Trends in surgical and nonsurgical aesthetic procedures: A 14-year analysis of the International Society of Aesthetic Plastic Surgery-ISAPS. Aesthetic Plast Surg 2024; 48 (20) 4217-4227
- 2 Guyuron B, Lee M. An effective algorithm for management of noses with thick skin. Aesthetic Plast Surg 2017; 41 (02) 381-387
- 3 Cobo R, Camacho JG, Orrego J. Integrated management of the thick-skinned rhinoplasty patient. Facial Plast Surg 2018; 34 (01) 3-8
- 4 Cobo R, Vitery L. Isotretinoin use in thick-skinned rhinoplasty patients. Facial Plast Surg 2016; 32 (06) 656-661
- 5 Baser B, Dev S, Mukhopadhyay S. A comprehensive approach to rhinoplasty for thick-skinned patients. J Laryngol Rhinol Otol 2024; 138 (05) 512-519
- 6 Klatsky SA, Manson PN. Aesthetic rhinoplasty in patients with thick nasal skin. Ann Plast Surg 1983; 11 (01) 10-16
- 7 Saadoun R, Risse EM, Crisan D, Veit JA. Dermatological assessment of thick-skinned patients before rhinoplasty-what may surgeons ask for?. Int J Dermatol 2023; 62 (05) 599-603
- 8 Afzalzadeh MR, Alizadeh A. Oral isotretinoin treatment in rhinoplasty: A review. World J Plast Surg 2023; 12 (03) 11-17
- 9 Oikarinen H, Oikarinen AI, Tan EM. et al. Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures. J Clin Invest 1985; 75 (05) 1545-1553
- 10 Janssen de Limpens AM. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol 1980; 103 (03) 319-323
- 11 Erkelens MN, Mebius RE. Retinoic acid and immune homeostasis: A balancing act. Trends Immunol 2017; 38 (03) 168-180
- 12 Lee B, Wu CY, Lin YW, Park SW, Wei LN. Synergistic activation of Arg1 gene by retinoic acid and IL-4 involves chromatin remodeling for transcription initiation and elongation coupling. Nucleic Acids Res 2016; 44 (16) 7568-7579
- 13 Dispenza MC, Wolpert EB, Gilliland KL. et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol 2012; 132 (09) 2198-2205
- 14 Chang J, Thangamani S, Kim MH, Ulrich B, Morris Jr SM, Kim CH. Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation. Eur J Immunol 2013; 43 (04) 967-978
- 15 Lin YW, Liu PS, Pook KA, Wei LN. Glyburide and retinoic acid synergize to promote wound healing by anti-inflammation and RIP140 degradation. Sci Rep 2018; 8 (01) 834
- 16 Abdelmalek M, Spencer J. Retinoids and wound healing. Dermatol Surg 2006; 32 (10) 1219-1230
- 17 Yahyavi S, Jahandideh H, Izadi M, Paknejad H, Kordbache N, Taherzade S. Analysis of the effects of isotretinoin on rhinoplasty patients. Aesthet Surg J 2020; 40 (12) NP657-NP665
- 18 Heppt MV, Kirchberger MC, Ruzicka T, Berking C, Heppt WJ. Indications and use of isotretinoin in facial plastic surgery. Facial Plast Surg 2018; 34 (01) 75-81
- 19 Alwabili M, Alotaibi N, Alamry S. Prosthesis extrusion post total ossicular replacement ossiculoplasty (TORP) following isotretinoin use: A case report and literature review of peri-operative isotretinoin safety. Ann Med Surg (Lond) 2022; 81: 104469
- 20 Hatami P, Balighi K, Asl HN, Goodarzi A, Aryanian Z. Isotretinoin and timing of procedural interventions: Clinical implications and practical points. J Cosmet Dermatol 2023; 22 (08) 2146-2149
- 21 Allen BC, Rhee JS. Complications associated with isotretinoin use after rhinoplasty. Aesthetic Plast Surg 2005; 29 (02) 102-106
- 22 Saadoun R, Riedel F, D'Souza A, Veit JA. Surgical and nonsurgical management of the nasal skin-soft tissue envelope. Facial Plast Surg 2021; 37 (06) 790-800
- 23 Prevost N, English JC. Isotretinoin: update on controversial issues. J Pediatr Adolesc Gynecol 2013; 26 (05) 290-293
- 24 Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2005; 24 (02) 92-102
- 25 Goodfield MJ, Cox NH, Bowser A. et al. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. Br J Dermatol 2010; 162 (06) 1172-1179
- 26 Kosins AM, Obagi ZE. Managing the difficult soft tissue envelope in facial and rhinoplasty surgery. Aesthet Surg J 2017; 37 (02) 143-157
- 27 Spring LK, Krakowski AC, Alam M. et al. Isotretinoin and timing of procedural interventions: A systematic review with consensus recommendations. JAMA Dermatol 2017; 153 (08) 802-809
- 28 Ungarelli LF, Hetem CM, Farina Junior JA. Is it safe to operate on patients taking isotretinoin?. Aesthetic Plast Surg 2016; 40 (01) 139-148
- 29 Waldman A, Bolotin D, Arndt KA. et al. ASDS Guidelines Task Force: Consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices, and skin surgery during and after isotretinoin use. Dermatol Surg 2017; 43 (10) 1249-1262
- 30 Nemati S, Banan R, Alizadeh A, Leili EK, Kerdari H. Ultrasonographic evaluation of long-term results of nasal tip defatting in rhinoplasty cases. Laryngoscope 2013; 123 (09) 2131-2135
- 31 Pavri S, Zhu VZ, Steinbacher DM. Postoperative edema resolution following rhinoplasty: A three-dimensional morphometric assessment. Plast Reconstr Surg 2016; 138 (06) 973e-979e
- 32 Kosins AM. Comprehensive diagnosis and planning for the difficult rhinoplasty patient: Applications in ultrasonography and treatment of the soft-tissue envelope. Facial Plast Surg 2017; 33 (05) 509-518
- 33 Yigit E, Rakici IT, Seden N, Manav V, Kaygisiz I, Yigit O. The impact of isotretinoin therapy on the nasal skin thickness and elasticity: An ultrasonography and elastography based assessment in relation to dose and duration of therapy. Aesthetic Plast Surg 2022; 46 (04) 1760-1770
- 34 Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
- 35 Sterne JA, Hernán MA, Reeves BC. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919
- 36 Sterne JAC, Savović J, Page MJ. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898
- 37 Silveira CSC, Azulay-Abulafia L, Barcaui EO, Silva MMM, Roxo ACW. Analysis of the use of isotretinoin as an adjuvant in rhinoplasty. Int J Dermatol 2024; 63 (02) 224-231
- 38 Sazgar AA, Majlesi A, Shooshtari S, Sadeghi M, Sazgar AK, Amali A. Oral isotretinoin in the treatment of postoperative edema in thick-skinned rhinoplasty: A randomized placebo-controlled clinical trial. Aesthetic Plast Surg 2019; 43 (01) 189-195
- 39 Nemati S, Golchay J, Iranfar K, Alizadeh A. Frequency of acne vulgaris and its exacerbation in facial and periorbital area after septorhinoplasty. Am J Otolaryngol 2013; 34 (05) 378-381
- 40 Bakhshaee M, Poursadegh M, Irani M, Yazdanpanah MJ, Fayyazi Bordbar MR, Rasoulian B. Post-rhinoplasty acne, frequency and role players. Iran J Otorhinolaryngol 2020; 32 (112) 319-325
- 41 Blough JT, Rohrich R, Wyles SP, Rohrich RJ. Dispelling the myths of isotretinoin and implications for rhinoplasty. Plast Reconstr Surg 2025; 155 (04) 689e-698e
- 42 Patel AA, Lee AH, Spiegel JH. Should isotretinoin be stopped prior to surgery?. Laryngoscope 2022; 132 (04) 724-725
- 43 Rastiboroujeni H, Bakhshaee M, Afzalzadeh MR, Nahidi Y. Topical tretinoin in the management of thick-skinned rhinoplasty patients. World J Plast Surg 2024; 13 (01) 50-56
- 44 Santana JC, Lisboa HVR, Camargo LA, Almeida RAM, Bueno LM. Isotretinoin use in rhinoplasty patients. Braz J Otorhinolaryngol 2025; 91 (04) 101592
- 45 Kandathil CK, Rossi-Meyer M, Saltychev M, Most SP. Effectiveness of isotretinoin administration in rhinoplasty: A systematic review. Facial Plast Surg Aesthet Med 2025; 27 (04) 387-396
